Two biggest U.S. drug purchasers keep key Novo Nordisk drugs on 2018 list

COPENHAGEN, Aug 2 (Reuters) – U.S. pharmacy benefit manager(PBM), CVS Health, said late Tuesday it had kept NovoNordisk’s key drugs on its 2018 list, removing someuncertainty over the U.S. market for the world’s top insulinmaker.
The post Two biggest U.S. drug purchasers keep key Novo Nordisk drugs on 2018 list appeared first on RocketNews | Top News Stories From Around the Globe.